Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $20.00 by Analysts at Scotiabank
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price dropped by analysts at Scotiabank from $28.00 to $20.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “sector perform” rating on the stock. Scotiabank’s price target points to a potential upside of 15.61% from the […]
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price dropped by analysts at Scotiabank from $28.00 to $20.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “sector perform” rating on the stock. Scotiabank’s price target points to a potential upside of 15.61% from the […]
